Literature DB >> 23559400

Tissue at risk in acute stroke patients treated beyond 8 h after symptom onset.

C Leiva-Salinas1, A Aghaebrahim, G Zhu, J T Patrie, W Xin, B C Lau, T Jovin, M Wintermark.   

Abstract

INTRODUCTION: The decision on thrombolytics administration is usually based on a generalized, rigid time-based rule rather than an individualized evaluation of the "tissue at risk of infarction" which is the target of the recanalization therapies. The goals of our article are to assess whether there is tissue at risk of infarction in a group of acute stroke patients treated beyond 8 h after symptom onset and to investigate the baseline imaging and clinical features that predict the fate of this tissue at risk.
METHODS: We retrospectively reviewed a series of patients with acute ischemic stroke treated with endovascular recanalization therapies beyond 8 h after symptom onset. The tissue at risk was calculated as the difference between the infarct volumes on baseline and follow-up imaging (infarct growth). We analyzed the epidemiological distribution of infarct growth, and we performed a multivariate regression analysis to identify the baseline variables that predict infarct growth.
RESULTS: Our study group included 75 patients (65 ± 13.8 years, baseline National Institutes of Health Stroke Scale 14 ± 4.9, time to treatment 15.2 ± 8.7 h). The mean infarct growth was 78.6 ± 95.0 cc (p < 0.001), and, overall, the infarct growth was greater when the baseline volume of infarct tissue was small (p < 0.001) and in the case of a unsuccessful arterial recanalization (p = 0.001).
CONCLUSIONS: There is potentially salvageable ischemic tissue at risk in acute stroke patients treated beyond 8 h after symptom onset.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23559400     DOI: 10.1007/s00234-013-1164-7

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  21 in total

1.  The fate of hypoxic tissue on 18F-fluoromisonidazole positron emission tomography after ischemic stroke.

Authors:  S J Read; T Hirano; D F Abbott; R Markus; J I Sachinidis; H J Tochon-Danguy; J G Chan; G F Egan; A M Scott; C F Bladin; W J McKay; G A Donnan
Journal:  Ann Neurol       Date:  2000-08       Impact factor: 10.422

2.  Recanalization after thrombolysis in stroke patients: predictors and prognostic implications.

Authors:  A Zangerle; S Kiechl; M Spiegel; M Furtner; M Knoflach; P Werner; A Mair; G Wille; C Schmidauer; K Gautsch; T Gotwald; S Felber; W Poewe; J Willeit
Journal:  Neurology       Date:  2007-01-02       Impact factor: 9.910

Review 3.  Reasons why few patients with acute stroke receive tissue plasminogen activator.

Authors:  Kara Z Bambauer; S Claiborne Johnston; Derek E Bambauer; Justin A Zivin
Journal:  Arch Neurol       Date:  2006-05

4.  Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset.

Authors:  Anthony J Furlan; Dirk Eyding; Gregory W Albers; Yasir Al-Rawi; Kennedy R Lees; Howard A Rowley; Christian Sachara; Mariola Soehngen; Steven Warach; Werner Hacke
Journal:  Stroke       Date:  2006-03-30       Impact factor: 7.914

5.  Endovascular treatment of acute ischemic stroke may be safely performed with no time window limit in appropriately selected patients.

Authors:  Alex Abou-Chebl
Journal:  Stroke       Date:  2010-07-22       Impact factor: 7.914

6.  The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase.

Authors:  Werner Hacke; Greg Albers; Yasir Al-Rawi; Julien Bogousslavsky; Antonio Davalos; Michael Eliasziw; Michael Fischer; Anthony Furlan; Markku Kaste; Kennedy R Lees; Mariola Soehngen; Steven Warach
Journal:  Stroke       Date:  2004-11-29       Impact factor: 7.914

7.  Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA.

Authors:  Wade S Smith; Michael H Lev; Joey D English; Erica C Camargo; Maggie Chou; S Claiborne Johnston; Gilberto Gonzalez; Pamela W Schaefer; William P Dillon; Walter J Koroshetz; Karen L Furie
Journal:  Stroke       Date:  2009-10-15       Impact factor: 7.914

8.  Good clinical outcome after ischemic stroke with successful revascularization is time-dependent.

Authors:  P Khatri; T Abruzzo; S D Yeatts; C Nichols; J P Broderick; T A Tomsick
Journal:  Neurology       Date:  2009-09-29       Impact factor: 9.910

9.  The cortical ischemic core and not the consistently present penumbra is a determinant of clinical outcome in acute middle cerebral artery occlusion.

Authors:  Tudor G Jovin; Howard Yonas; James M Gebel; Emanuel Kanal; Yue Fang Chang; Stephen Z Grahovac; Steven Goldstein; Lawrence R Wechsler
Journal:  Stroke       Date:  2003-09-18       Impact factor: 7.914

10.  Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole.

Authors:  S J Read; T Hirano; D F Abbott; J I Sachinidis; H J Tochon-Danguy; J G Chan; G F Egan; A M Scott; C F Bladin; W J McKay; G A Donnan
Journal:  Neurology       Date:  1998-12       Impact factor: 9.910

View more
  2 in total

1.  Response to endovascular reperfusion is not time-dependent in patients with salvageable tissue.

Authors:  Maarten G Lansberg; Carlo W Cereda; Michael Mlynash; Nishant K Mishra; Manabu Inoue; Stephanie Kemp; Søren Christensen; Matus Straka; Greg Zaharchuk; Michael P Marks; Roland Bammer; Gregory W Albers
Journal:  Neurology       Date:  2015-07-29       Impact factor: 9.910

Review 2.  [From stroke to reperfusion : How can we be faster?]

Authors:  F Härtig; J Purrucker; C Hametner; S Poli
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-10-12       Impact factor: 0.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.